The BDNF Val66Met Polymorphism Has Opposite Effects on Memory Circuits of Multiple Sclerosis Patients and Controls

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Fera, Francesco ^a   Passamonti, Luca ^a,b   Cerasa, Antonio ^b   Gioia, Maria Cecilia ^b   Liguori, Maria ^c   Manna, Ida ^c   Valentino, Paola ^a   Quattrone, Aldo ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b CNR   (Italy)

^c INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; VALINE; BRAIN DERIVED NEUROTROPHIC FACTOR, HUMAN; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; PRIMER DNA;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BRAIN DERIVED NEUROTROPHIC FACTOR GENE; BRAIN FUNCTION; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EPISODIC MEMORY; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPING TECHNIQUE; HIPPOCAMPUS; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL TASK; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; NEUROIMAGING; OUTCOME ASSESSMENT; POSTERIOR CINGULATE; RESPONSE TIME; STIMULUS RESPONSE; TASK PERFORMANCE; VISUAL MEMORY; VISUAL STIMULATION; CASE CONTROL STUDY; CINGULATE GYRUS; GENETICS; GENOTYPE; MEMORY DISORDER; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; GENOTYPE; GYRUS CINGULI; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY DISORDERS; MULTIPLE SCLEROSIS; NEURONAL PLASTICITY; NEUROPSYCHOLOGICAL TESTS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 84876152308     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061063     Document Type: Article

References (75)

1. Thornton AE, Raz N, Tucke KA, (2002) Memory in multiple sclerosis: contextual encoding deficits. J Int Neuropsychol Soc 8: 395-409.
2. Benedict RH, Zivadinov R, (2011) Risk factors for and management of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol 7: 332-342.
3. Charil A, Zijdenbos AP, Taylor J, Boelman C, Worsley KJ, et al. (2003) Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets. Neuroimage 19: 532-544.
4. Prokopenko I, Montomoli C, Ferrai R, Musu L, Piras ML, et al. (2003) Risk for relatives of patients with multiple sclerosis in central Sardinia, Italy. Neuroepidemiology 22: 290-296.
5. Piras MR, Magnano I, Canu ED, Paulus KS, Satta WM, et al. (2003) Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings. J Neurol Neurosurg Psychiatry 74: 878-885.
6. Staffen W, Mair A, Zauner H, Unterrainer J, Niederhofer H, et al. (2002) Cognitive function and fMRI in patients with multiple sclerosis: evidence for compensatory cortical activation during an attention task. Brain 125: 1275-1282.
7. Rocca MA, Ceccarelli A, Rodegher M, Misci P, Riccitelli G, et al. (2010) Preserved brain adaptive properties in patients with benign multiple sclerosis. Neurology 74: 142-149.
8. Mancini L, Ciccarelli O, Manfredonia F, Thornton JS, Agosta F, et al. (2009) Short-term adaptation to a simple motor task: a physiological process preserved in multiple sclerosis. Neuroimage 45: 500-511.
9. Rocca MA, Absinta M, Ghezzi A, Moiola L, Comi G, et al. (2009) Is a preserved functional reserve a mechanism limiting clinical impairment in pediatric MS patients? Hum Brain Mapp 30: 2844-2851.
10. Rocca MA, Valsasina P, Ceccarelli A, Absinta M, Ghezzi A, et al. (2009) Structural and functional MRI correlates of Stroop control in benign MS. Hum Brain Mapp 30: 276-290.
11. Rocca MA, Colombo B, Falini A, Ghezzi A, Martinelli V, et al. (2005) Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes. Lancet Neurol 4: 618-626.
12. Rocca MA, Falini A, Colombo B, Scotti G, Comi G, et al. (2002) Adaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage. Ann Neurol 51: 330-339.
13. Hulst HE, Schoonheim MM, Roosendaal SD, Popescu V, Schweren LJ, et al. (2011) Functional adaptive changes within the hippocampal memory system of patients with multiple sclerosis. Hum Brain Mapp.
14. Kern KC, Ekstrom AD, Suthana NA, Giesser BS, Montag M, et al. (2012) Fornix damage limits verbal memory functional compensation in multiple sclerosis. Neuroimage 59: 2932-2940.
15. Fisher PM, Munoz KE, Hariri AR, (2008) Identification of neurogenetic pathways of risk for psychopathology. Am J Med Genet C Semin Med Genet 148C: 147-153.
16. Bigos KL, Hariri AR, (2007) Neuroimaging: technologies at the interface of genes, brain, and behavior. Neuroimaging Clin N Am 17: 459-467, viii.
17. Viding E, Williamson DE, Hariri AR, (2006) Developmental imaging genetics: challenges and promises for translational research. Dev Psychopathol 18: 877-892.
18. Brown SM, Hariri AR, (2006) Neuroimaging studies of serotonin gene polymorphisms: exploring the interplay of genes, brain, and behavior. Cogn Affect Behav Neurosci 6: 44-52.
19. Hariri AR, Drabant EM, Weinberger DR, (2006) Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing. Biol Psychiatry 59: 888-897.
20. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, et al. (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112: 257-269.
21. Greenberg ME, Xu B, Lu B, Hempstead BL, (2009) New insights in the biology of BDNF synthesis and release: implications in CNS function. J Neurosci 29: 12764-12767.
22. Hariri AR, Goldberg TE, Mattay VS, Kolachana BS, Callicott JH, et al. (2003) Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 23: 6690-6694.
23. Lu B, (2003) BDNF and activity-dependent synaptic modulation. Learn Mem 10: 86-98.
24. Ninan I, Bath KG, Dagar K, Perez-Castro R, Plummer MR, et al. (2010) The BDNF Val66Met polymorphism impairs NMDA receptor-dependent synaptic plasticity in the hippocampus. J Neurosci 30: 8866-8870.
25. Javeri S, Rodi M, Tary-Lehmann M, Lehmann PV, Addicks K, et al. (2010) Involvement of brain-derived neurotrophic factor (BDNF) in MP4-induced autoimmune encephalomyelitis. Clin Immunol 137: 181-189.
26. Lee DH, Geyer E, Flach AC, Jung K, Gold R, et al. (2012) Central nervous system rather than immune cell-derived BDNF mediates axonal protective effects early in autoimmune demyelination. Acta Neuropathol 123: 247-258.
27. Liguori M, Fera F, Gioia MC, Valentino P, Manna I, et al. (2007) Investigating the role of brain-derived neurotrophic factor in relapsing-remitting multiple sclerosis. Genes Brain Behav 6: 177-183.
28. Patanella AK, Zinno M, Quaranta D, Nociti V, Frisullo G, et al. (2010) Correlations between peripheral blood mononuclear cell production of BDNF, TNF-alpha, IL-6, IL-10 and cognitive performances in multiple sclerosis patients. J Neurosci Res 88: 1106-1112.
29. Dinacci D, Tessitore A, Russo A, De Bonis ML, Lavorgna L, et al. (2011) BDNF Val66Met polymorphism and brain volumes in multiple sclerosis. Neurol Sci 32: 117-123.
30. Ramasamy DP, Ramanathan M, Cox JL, Antulov R, Weinstock-Guttman B, et al. (2011) Effect of Met66 allele of the BDNF rs6265 SNP on regional gray matter volumes in patients with multiple sclerosis: A voxel-based morphometry study. Pathophysiology 18: 53-60.
31. Zivadinov R, Weinstock-Guttman B, Benedict R, Tamano-Blanco M, Hussein S, et al. (2007) Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor. Hum Mol Genet 16: 2659-2668.
32. Dennis NA, Cabeza R, Need AC, Waters-Metenier S, Goldstein DB, et al. (2011) Brain-derived neurotrophic factor val66met polymorphism and hippocampal activation during episodic encoding and retrieval tasks. Hippocampus 21: 980-989.
33. Smith GN, Thornton AE, Lang DJ, Macewan GW, Ehmann TS, et al. (2012) Hippocampal volume and the brain-derived neurotrophic factor Val66Met polymorphism in first episode psychosis. Schizophr Res 134: 253-259.
34. Bueller JA, Aftab M, Sen S, Gomez-Hassan D, Burmeister M, et al. (2006) BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry 59: 812-815.
35. Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, et al. (2004) The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 24: 10099-10102.
36. Gerritsen L, Tendolkar I, Franke B, Vasquez AA, Kooijman S, et al. (2012) BDNF Val66Met genotype modulates the effect of childhood adversity on subgenual anterior cingulate cortex volume in healthy subjects. Mol Psychiatry 17: 597-603.
37. Joffe RT, Gatt JM, Kemp AH, Grieve S, Dobson-Stone C, et al. (2009) Brain derived neurotrophic factor Val66Met polymorphism, the five factor model of personality and hippocampal volume: Implications for depressive illness. Hum Brain Mapp 30: 1246-1256.
38. Stein JL, Medland SE, Vasquez AA, Hibar DP, Senstad RE, et al. (2012) Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet 44: 552-561.
39. Cerasa A, Tongiorgi E, Fera F, Gioia MC, Valentino P, et al. (2010) The effects of BDNF Val66Met polymorphism on brain function in controls and patients with multiple sclerosis: an imaging genetic study. Behav Brain Res 207: 377-386.
40. Epstein R, Kanwisher N, (1998) A cortical representation of the local visual environment. Nature 392: 598-601.
41. Kohler S, Crane J, Milner B, (2002) Differential contributions of the parahippocampal place area and the anterior hippocampus to human memory for scenes. Hippocampus 12: 718-723.
42. Prince SE, Dennis NA, Cabeza R, (2009) Encoding and retrieving faces and places: distinguishing process- and stimulus-specific differences in brain activity. Neuropsychologia 47: 2282-2289.
43. Sestieri C, Corbetta M, Romani GL, Shulman GL, (2011) Episodic memory retrieval, parietal cortex, and the default mode network: functional and topographic analyses. J Neurosci 31: 4407-4420.
44. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, et al. (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69: 292-302.
45. Liguori M, Fera F, Patitucci A, Manna I, Condino F, et al. (2009) A longitudinal observation of brain-derived neurotrophic factor mRNA levels in patients with relapsing-remitting multiple sclerosis. Brain Res 1256: 123-128.
46. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC.
47. Kurtzke JF, (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452.
48. Oldfield RC, (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9: 97-113.
49. Wechsler D (1981) Manual for the Wechsler Adult Intelligence Scale-revised; Corporation NYP, editor.
50. Nelson HE, (1976) A modified card sorting test sensitive to frontal lobe defects. Cortex 12: 313-324.
51. Rey A (1958) Memorisation d'une serie de 15 mots en 5 repetitions; Rey A, editor: Presses Universitaries des France.
52. Benton AL, Varney NR, Hamsher KD, (1978) Visuospatial judgment. A clinical test. Arch Neurol 35: 364-367.
53. Rey A (1968) Reattivo della figura complessa; Speciali FO, editor.
54. Benton AL, Hamsher KD, Sivan AB (1994) Multilingual aphasia examination; Associates A, editor. Iowa City.
55. Amato MP, Ponziani G, Siracusa G, Sorbi S, (2001) Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol 58: 1602-1606.
56. Cerasa A, Fera F, Gioia MC, Liguori M, Passamonti L, et al. (2006) Adaptive cortical changes and the functional correlates of visuo-motor integration in relapsing-remitting multiple sclerosis. Brain Res Bull 69: 597-605.
57. Gioia MC, Cerasa A, Liguori M, Passamonti L, Condino F, et al. (2007) Impact of individual cognitive profile on visuo-motor reorganization in relapsing-remitting multiple sclerosis. Brain Res 1167: 71-79.
58. Gioia MC, Cerasa A, Valentino P, Fera F, Nistico R, et al. (2009) Neurofunctional correlates of personality traits in relapsing-remitting multiple sclerosis: an fMRI study. Brain Cogn 71: 320-327.
59. Passamonti L, Cerasa A, Liguori M, Gioia MC, Valentino P, et al. (2009) Neurobiological mechanisms underlying emotional processing in relapsing-remitting multiple sclerosis. Brain 132: 3380-3391.
60. Hamilton M, (1959) The assessment of anxiety states by rating. Br J Med Psychol 32: 50-55.
61. Solari A, Motta A, Mendozzi L, Aridon P, Bergamaschi R, et al. (2004) Italian version of the Chicago multiscale depression inventory: translation, adaptation and testing in people with multiple sclerosis. Neurol Sci 24: 375-383.
62. Stark CE, Squire LR, (2001) When zero is not zero: the problem of ambiguous baseline conditions in fMRI. Proc Natl Acad Sci U S A 98: 12760-12766.
63. Dawant BM, Hartmann SL, Thirion JP, Maes F, Vandermeulen D, et al. (1999) Automatic 3-D segmentation of internal structures of the head in MR images using a combination of similarity and free-form transformations: Part I, Methodology and validation on normal subjects. IEEE Trans Med Imaging 18: 909-916.
64. Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, et al. (2002) Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 17: 479-489.
65. De Stefano N, Bartolozzi ML, Nacmias B, Zipoli V, Mortilla M, et al. (2004) Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis. Arch Neurol 61: 536-540.
66. Cerasa A, Valentino P, Chiriaco C, Pirritano D, Nistico R, et al. (2012) MR imaging and cognitive correlates of relapsing-remitting multiple sclerosis patients with cerebellar symptoms. J Neurol.
67. Friston KJ, Holmes AP, Worsley KJ, Poline J-P, Frith CD, et al. (1994) Statistical parametric maps in functional imaging: A general linear approach. Hum Brain Mapp 2: 189-210.
68. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, et al. (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15: 273-289.
69. Friston KJ, (1997) Testing for anatomically specified regional effects. Hum Brain Mapp 5: 133-136.
70. Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, et al. (1996) A unified statistical approach for determining significant signals in images of cerebral activation. Human Brain Mapping 4: 58-73.
71. Gitelman DR, Penny WD, Ashburner J, Friston KJ, (2003) Modeling regional and psychophysiologic interactions in fMRI: the importance of hemodynamic deconvolution. Neuroimage 19: 200-207.
72. Vann SD, Aggleton JP, Maguire EA, (2009) What does the retrosplenial cortex do? Nat Rev Neurosci 10: 792-802.
73. Oroszi G, Lapteva L, Davis E, Yarboro CH, Weickert T, et al. (2006) The Met66 allele of the functional Val66Met polymorphism in the brain-derived neurotrophic factor gene confers protection against neurocognitive dysfunction in systemic lupus erythematosus. Ann Rheum Dis 65: 1330-1335.
74. Lau JY, Goldman D, Buzas B, Hodgkinson C, Leibenluft E, et al. (2010) BDNF gene polymorphism (Val66Met) predicts amygdala and anterior hippocampus responses to emotional faces in anxious and depressed adolescents. Neuroimage 53: 952-961.
75. Voineskos AN, Lerch JP, Felsky D, Shaikh S, Rajji TK, et al. (2011) The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease. Arch Gen Psychiatry 68: 198-206.